Celltrion seeks approval of Avastin biosimilar product in the EU
Celltrion said it has finalized the process of applying for approval of CT-P16, a biosimilar of Avastin (ingredient: bevacizumab), with...
Month: October 2021
Celltrion seeks product approval for the biosimilar Avastin in the EU
Celltrion has declared that it has completed the process of requesting approval of CT-P16, a biosimilar of Avastin (ingredient: bevacizumab),...
Syntellix Receives Product Approval for India, Opening a Fast-Growing Market with 1.38 Billion People
Syntellix Claassen CEO: "The biggest and most important success story in the company's history" - Indian CDSCO Grants Approvals for...
Syntellix Receives Product Approval For India, Opening Fast-Growing Market With 1.38 Billion People
HANOVER, Germany, October 7, 2021 / CNW / - india The Central Drugs Standard Control Organization (CDSCO) has granted Syntellix...
Celltrion requests approval of Regkirona’s product from EU
Celltrion said it submitted a Marketing Authorization (MAA) application for Regkirona, a treatment for Covid-19, to the European Medicines Agency...
Celltrion seeks approval of Regkirona’s product from the EU
Celltrion said it submitted a Marketing Authorization (MAA) application for Regkirona, a treatment for Covid-19, to the European Medicines Agency...
Drugmaker creates jobs and invests $30 million in North Carolina expansion
RESEARCH TRIANGLE PARK – Cambrex Corp., a contract manufacturer of small molecule therapeutics with major facilities in High Point and...
Drug maker creates jobs, invests $ 30 million in CN expansion
RESEARCH TRIANGLE PARK - Cambrex Corp., a contract manufacturer of small molecule therapies with major facilities in High Point and...